Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 10/20 | 0.60 |
| ▸ | IKZF2 | Q9UKS7 | 7/20 | 0.49 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.48 |
| ▸ | WIZ | O95785 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24816763 | 0.94 | CRBN (0.58) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL31070691 | 0.92 | CRBN (0.60) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL20234306 | 0.89 | CRBN (0.65) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL30273536 | 0.89 | CRBN (0.65) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL20046231 | 0.89 | CRBN (0.65) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL22291438 | 0.88 | IKZF2 (0.52) | CRBNIKZF2WIZ | |
| SCHEMBL30183833 | 0.88 | IKZF2 (0.52) | CRBNIKZF2WIZ | |
| SCHEMBL20231474 | 0.86 | CRBN (0.67) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL20046262 | 0.86 | CRBN (0.67) | CRBNIKZF2CSNK1A1WIZ | |
| SCHEMBL31070701 | 0.85 | CRBN (0.61) | CRBNIKZF2CSNK1A1WIZ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118556048-A | Sulfur/oxygen substituted glutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118556048-A | Sulfur/oxygen substituted glutarimide isoindolinone skeleton-based compound and application thereof | 标新生物医药科技(上海)有限公司 | 2024-08-27 | — | — | CN | disclosed |